Works by Stove, Christophe


Results: 130
    1
    2
    3
    4
    5
    6
    7

    Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.

    Published in:
    Clinical Toxicology (15563650), 2017, v. 55, n. 5, p. 338, doi. 10.1080/15563650.2017.1287373
    By:
    • Abouchedid, Rachelle;
    • Hudson, Simon;
    • Thurtle, Natalie;
    • Yamamoto, Takahiro;
    • Ho, James H.;
    • Bailey, George;
    • Wood, Michelle;
    • Sadones, Nele;
    • Stove, Christophe P.;
    • Dines, Alison;
    • Archer, John R. H.;
    • Wood, David M.;
    • Dargan, Paul I.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Roles for neuregulins in human cancer.

    Published in:
    Clinical & Experimental Metastasis, 2005, v. 21, n. 8, p. 665, doi. 10.1007/s10585-004-6917-6
    By:
    • Stove, Christophe;
    • Bracke, Marc
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists.

    Published in:
    Drug Testing & Analysis, 2024, v. 16, n. 9, p. 915, doi. 10.1002/dta.3609
    By:
    • Norman, Caitlyn;
    • Webling, Kristin;
    • Kyslychenko, Oleksandra;
    • Reid, Robert;
    • Krotulski, Alex J.;
    • Farrell, Ryan;
    • Deventer, Marie H.;
    • Liu, Huiling;
    • Connolly, Matthew J.;
    • Guillou, Claude;
    • Vinckier, Inge M. J.;
    • Logan, Barry K.;
    • NicDaéid, Niamh;
    • McKenzie, Craig;
    • Stove, Christophe P.;
    • Gréen, Henrik
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48

    Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1412, doi. 10.1002/dta.3054
    By:
    • Grafinger, Katharina Elisabeth;
    • Vandeputte, Marthe M.;
    • Cannaert, Annelies;
    • Ametovski, Adam;
    • Sparkes, Eric;
    • Cairns, Elizabeth;
    • Juchli, Patrick Osamu;
    • Haschimi, Belal;
    • Pulver, Benedikt;
    • Banister, Samuel D.;
    • Stove, Christophe P.;
    • Auwärter, Volker
    Publication type:
    Article
    49

    Obituary Peter Blanckaert.

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1464, doi. 10.1002/dta.3039
    By:
    • Stove, Christophe
    Publication type:
    Article
    50

    Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptors

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1383, doi. 10.1002/dta.3037
    By:
    • Pike, Edward;
    • Grafinger, Katharina Elisabeth;
    • Cannaert, Annelies;
    • Ametovski, Adam;
    • Luo, Jia Lin;
    • Sparkes, Eric;
    • Cairns, Elizabeth A.;
    • Ellison, Ross;
    • Gerona, Roy;
    • Stove, Christophe P.;
    • Auwärter, Volker;
    • Banister, Samuel D.
    Publication type:
    Article